Span Divergent Ltd 06 Nov 2026 12:00 AM
Span Divergent Ltd consolidated sales up 502.25% on year in Q3FY2026,
Span Divergent Ltd share price ticked higher by 4.97% to Rs 28.08 after the company`s net profit tumbled by 36.97% to Rs 0.75 crore, while revenue from operations gained significantly 502.25% to Rs 5.36 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.82 lakh crore, gaining 5.09%. It has improved by 2.18% over last one week and moved up slightly by 2.72% in last one month while the market capitalization of Span Divergent Ltd has gained 14.67% and 13.01% in the same period respectively. Profit before tax (PBT) of Span Divergent Ltd stood at Rs 0.76 crore in Q3 FY26, rallying 375.00% year-on-year, and tumbling by 33.91% quarter-on-quarter. EBITDA came in at Rs 2 crore, expanding by 622.73% YoY and surging by 19.55% sequentially. Total expenses jumped by 189.61% to Rs 6.69 crore in Q3FY26 over Q3FY25. During the quarter, employee benefits expense was at Rs 0.68 crore, witnessing a strong rise of 44.68% YoY. For the TTM ended FY26, revenue from operations soared by 97.66% to Rs 16.9 crore, while net profit jumped 132.28% to Rs 2.95 crore, compared to previous TTM. EBITDA plunged by 274% to Rs 3.88 crore, and PBT surged 168.52% to Rs 2.9 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 0.22 crore in FY26, as against Rs 1.86 crore in FY25. Span Divergent Ltd surged by 22.62% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 4.80% during the same period.
Span Divergent Ltd 30 Oct 2026 12:00 AM
Span Divergent Ltd. to review financial results at November board meeting, closing trading window,
Span Divergent Ltd., formerly Span Diagnostics Ltd., will hold a board meeting on November 5, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, triggering a trading window closure for directors, officers, and designated persons until 48 hours after the results are declared.
Span Divergent Ltd 09 Oct 2026 12:00 AM
Span Divergent confirms compliance with SEBI regulations for the quarter ended September 30, 2026,
Span Divergent Ltd., formerly Span Diagnostics Ltd., informed the Bombay Stock Exchange that its Registrar and Transfer Agent, Accurate Securities and Registry Private Limited, has confirmed compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Span Divergent Ltd 21 Sep 2026 12:00 AM
Span Divergent Ltd. will restrict insider trading around financial results announcements,
Span Divergent Ltd., formerly Span Diagnostics Ltd., will close its trading window for promoters, directors, designated persons, and their relatives from October 1, 2026, until forty-eight hours after the announcement of the company’s standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations.
Span Divergent Ltd 11 Aug 2026 12:00 AM
Span Divergent Ltd consolidated sales down 80.57% on year in Q2FY2026, net profit saw a mild growth of 6.25%,
Span Divergent Ltd share price ticked higher by 4.99% to Rs 33.89 after the company`s net profit inched up 6.25% to Rs 1.19 crore, while revenue from operations plunged by 80.57% to Rs 0.89 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.56 lakh crore, easing 4.63%. It has marginally improved by 0.56% over last one week and climbed by 13.27% in last one month while the market capitalization of Span Divergent Ltd has improved by 6.81% and 7.55% in the same period respectively. Profit before tax (PBT) of Span Divergent Ltd stood at Rs 1.15 crore in Q2 FY26, jumping 721.43% year-on-year, and rising 1.77% quarter-on-quarter. EBITDA came in at Rs 1 crore, declining 4.32% YoY and expanding by 33.00% sequentially. Total expenses tumbled by 60.17% to Rs 2.31 crore in Q2FY26 over Q2FY25. During the quarter, employee benefits expense was at Rs 0.47 crore, plunging by 16.07% YoY. For the TTM ended FY26, revenue from operations slumped by 26.86% to Rs 8.55 crore, while net profit tanked by 262.82% to Rs 1.27 crore, compared to previous TTM. EBITDA saw a sharp decline of 186% to Rs 1.82 crore, and PBT collapsed by 235% to Rs 1.08 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 1.86 crore in FY26, as against Rs 2.5 crore in FY25. Span Divergent Ltd surged by 69.87% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 2.56% during the same period.
Subscribe for our
newsletter
Open Account Now